Melt Pharmaceuticals, Inc. (MELT)

Melt Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jan 4, 2023.

Stock Price: Pending

IPO price not available yet

Melt Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	-0.72	-0.94	-
Debt / EBITDA Ratio	-1.73	-2.32	-
Debt / FCF Ratio	-2.07	-3.32	-
Quick Ratio	0.35	0.72	2.20
Interest Coverage	-5.81	-10.43	-
Return on Equity (ROE)	48.67%	44.33%	50.81%
Return on Assets (ROA)	-	-59.00%	-153.52%
Return on Capital (ROIC)	145.89%	627.93%	50.70%
Return on Capital Employed (ROCE)	49.52%	136.24%	-279.30%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).